WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.

Faculty

• 

• Todd M. Bauer, MD

  Associate Director, Drug Development
  Physician Lead, Personalized Medicine
  Sarah Cannon Research Institute
  Tennessee Oncology, PLLC
  Nashville, Tennessee, United States

  Disclosures

  Todd M. Bauer, MD, has the following relevant financial relationships:
  Consultant or advisor for: AstraZeneca; Bayer; Bristol Myers Squibb; Lilly; Pfizer
  Speaker or member of speakers bureau for: Bristol Myers Squibb (former); Lilly
  Research funding from: Boehringer Ingelheim; LOXO/Lilly; Pfizer

• 

• Ibiayi Dagogo-Jack, MD

  Assistant Professor of Medicine
  Massachusetts General Hospital
  Department of Medicine
  Massachusetts General Hospital
  Boston, Massachusetts, United States

  Disclosures

  Ibiayi Dagogo-Jack, MD, has the following relevant financial relationships:
  Consultant or advisor for: AstraZeneca; Bayer; Boehringer Ingelheim; BostonGene; Bristol Myers Squibb; Genentech; Janssen; Novocure; Pfizer; Sanofi/Genzyme; Syros; Xcovery
  Research funding from: Array; Genentech; Novartis; Pfizer; Vivace

• 

• Enriqueta Felip, MD, PhD

  Professor of Medicine
  Universitat de Vic
  Head, Thoracic, Head and Neck Cancer Unit,
  Department of Oncology
  Vall d'Hebron University Hospital
  Barcelona, Spain

  Disclosures

  Enriqueta Felip, MD, PhD, has the following relevant financial relationships:
  Consultant or advisor for: AbbVie; Amgen; AstraZeneca; Bayer; Bristol Myers Squibb; Daichii Sankyo; Eli Lilly; F.Hoffmann-La Roche; Glaxo Smith Kline; Janssen; Merck; Merck Sharp & Dohme; Novartis; Peptomyc; Pfizer; Sanofi; Takeda
  Speaker or member of speakers bureau for: AstraZeneca; Bristol Myers Squibb; Eli Lilly; F. Hoffmann-La Roche; Janssen; Medical Trends; Merck; Merck Sharp & Dohme; Pfizer; Sanofi; Takeda
  Research funding from: Fundación Merck Salud; Merck Healthcare KGaA
  Other: Grifols (independent member of the board)

• 

• Solange Peters, MD, PhD

  Professor of Oncology
  Medical Oncology Chair
  Lausanne University Hospital
  Lausanne, Switzerland

  Disclosures

  Solange Peters, MD, PhD, has the following relevant financial relationships:
  Consultant or advisor for: AbbVie; Amgen; Arcus; AstraZeneca; Bayer; Beigene; Biocartis; BioInvent; Blueprint Medicines; Boehringer Ingelheim; Bristol Myers Squibb; Clovis Oncology; Daiichi Sankyo; Debiopharm; Eli Lilly; F-Star Therapeutics; Fishawack; Foundation Medicine; Genzyme; Gilead; GlaxoSmithKline; Illumina; IQVIA; Incyte; iTeos; Janssen; Merck Sharp & Dohme; Merck Serono; Merrimack Pharmaceuticals; Novartis; Novocure; Pharma Mar; Phosplatin Therapeutics; PER; Pfizer; Regeneron; Roche/Genentech; Sanofi; Seagen Inc., formerly Seattle Genetics Inc.; Takeda; Vaccibody
  Speaker or member of speakers bureau for: AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; Eli Lilly; Foundation Medicine; Illumina; Merck Sharp & Dohme; Mirati Therapeutics; Novartis; PER; Pfizer; Roche/Genentech; RTP Pharma; Sanofi; Takeda
  Research funding from: Amgen; AstraZeneca; Beigene; Bristol Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Roche/Genentech

Editors

• Megan Cannon, PhD

  Medical Education Director, WebMD Global, LLC

  Disclosures

  Megan Cannon, PhD, has no relevant financial relationships.

• Eloise Ballard, PhD

  Scientific Content Manager, WebMD Global, LLC

  Disclosures

  Eloise Ballard, PhD, has no relevant financial relationships.

Compliance Reviewer

• Leigh Schmidt, MSN, RN, CNE, CHCP

  Associate Director, Accreditation and Compliance

  Disclosures

  Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.